ELAN - Company ID 0001739104
The table below shows Elanco Animal Health Inc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $13.00M | -$4.00M | $2.00M | -$145.00M | -$62.00M | $22.00M |
| Capital expenditure | $51.00M | $65.00M | $24.00M | $24.00M | $19.00M | $18.00M |
| Investing cash flow | -$60.00M | -$58.00M | $37.00M | -$55.00M | -$29.00M | $10.00M |
| Dividends paid | - | - | - | - |
Elanco Animal Health Inc reported operating cash flow of $560.00M for fiscal year 2025. That is up 3.5% from $541.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $155.90M (FY 2016) to $560.00M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$65.00M | $52.00M | -$27.00M | $174.00M | -$200.00M | $2.00M |